PROGRAM AGENDA
*Panels are in development and speakers are subject to change.
Registration + Networking Breakfast
7:00 – 8:00 a.m.
McCormick Place Convention Center, E354
Welcome!
8:00 – 8:10 a.m.
Program Chair Gil Kliman, MD
Program Co-Chairs Allen C. Ho, MD and Julie Schallhorn, MD
A Wild Ride: 2022 in Review
8:10 – 9:00 a.m.
Moderator: Stephen D. McLeod, MD
CEO, American Academy of Ophthalmology
How Will the 2022 Midterm Elections Impact Healthcare?
-
Jeffrey Kimbell, President & CEO, Kimbell & Associates
Political insider Jeff Kimbell prognosticates on the outcomes of the 2022 and 2024 US elections and the potential impact on the life sciences community.
Ophthalmology Year in Review
-
Kristen Harmon Ingenito, Director of Ophthalmics, Market Scope
Start the day with a data-driven and sometimes surprising look at the business of Ophthalmology.
Panel:
-
Wiley A. Chambers, MD, Food & Drug Administration
-
Malvina B. Eydelman, MD, Food & Drug Administration
-
Andrew Gitkin, Raymond James
-
Peter Menziuso, Company Group Chairman, Johnson & Johnson Vision
-
Euan S. Thomson, PhD, President, Ophthalmic Devices and Head of Digital Business, Carl Zeiss Meditec
Old Money/New Money: Financing Innovation
9:00 – 9:30 a.m.
Moderator: Gil Kliman, MD
A diverse, multigenerational panel of investment experts explore the interdependent roles of venture capital, private financing and global strategics in funding the next wave of eye care innovation.
Panel:
-
Franck Leveiller, Alcon
-
William Link, PhD, Flying-L-Partners
-
Mariam Maghribi, PhD, MBA, Shifamed
-
Biren Mehta, Venture Investments, Johnson & Johnson
-
Jeffry Weinhuff, Visionary Ventures
Networking Break
9:30 – 10:00 a.m.
Enjoy refreshments and connect with your colleagues.
Presbyopic Treatment: Where We Go From Here
10:00 – 10:45 a.m.
A timely assessment of the real-world data driving a new generation of treatments and medical vs. surgical solutions for patients.
Moderators: Zaina Al-Mohtaseb, MD and Julie Schallhorn, MD
Panel:
-
Jeannette Bankes, Alcon
-
Sumit Garg, MD, LensGen
-
Yari L. Mitchell, AcuFocus, Inc.
-
Erin Powers, BVI Medical
-
Neda Shamie, MD, Visus Therapeutics
-
Ramin Valian, Allergan, an AbbVie Company
The Future of AMD
10:45 – 11:45 a.m.
Seven innovative retina and AI companies will showcase the newest treatments and technologies, while panel experts analyze the clinical and market opportunities.
Moderators: Robert L. Avery, MD and Allen C. Ho, MD
Panel:
-
Megan Baldwin, PhD, Opthea
-
Durga Borkar, MD, Verana
-
Wiley A. Chambers, MD, Food & Drug Administration
-
Pravin Dugel, MD, IvericBio
-
Cedric Francois, MD, PhD, Apellis
-
Kester Nahen, PhD, Notal Vision, Inc.
-
Stephen Pakola, MD, RegenXBio
Presentations:
-
Apellis, Cedric Francois, MD, PhD, Co-Founder and CEO
-
IvericBio Dhaval B. Desai, SVP & Chief Development Officer
-
Gyroscope, a Novartis Company, J. Jill Hopkins, MD, FRSCS, SVP, Global Head Ophthalmology Development Unit
-
RegenXBio, Stephen Pakola, MD, Chief Medical Officer
-
Opthea, Megan Baldwin, PhD, CEO and Managing Director
-
Verana, Durga Borkar, MD, Medical Advisor
-
Notal Vision, Inc., Kester Nahen, PhD, CEO
Defining Clinically Relevant Endpoints in Approval Trials
11:45 a.m. – 12:30 p.m.
Government, academic, and industry experts offer perspectives on benchmarking practices that accurately characterize the effectiveness of treatments in clinical studies and meet regulatory requirements.
Moderators: Mark S. Humayun, MD, PhD and Arsham Sheybani, MD
Panel:
-
Mark S. Blumenkranz, MD, MMS, Byers Eye Institute at Stanford University
-
Wiley A. Chambers, MD, Food & Drug Administration
-
Terry Dagnon, Outlook Therapeutics
-
Malvina B. Eydelman, MD, Food & Drug Administration
-
Peter K. Kaiser, MD, Cleveland Clinic Lerner College of Medicine
-
Omar Sadaruddin, MD, Santen
-
Matt Schlenker, MS, MD, University of Toronto
Lunch and Networking Break
12.:30 – 1:15 p.m.
Buffet served.
The Winning Pitch Challenge
1:15 – 2:00 p.m.
The 'Shark Tank' -styled competition returns to the Eyecelerator stage. Three early-stage companies will compete for free access to experienced mentors, networking opportunities, exposure to financial resources, and up to $45,000 in prize money.
Moderators: John P. Berdahl, MD and Vance M. Thompson, MD
Pitch Finalists
-
Vincente Diaz, MD, MBA, Sustained Drug Delivery
-
Alejandro Navas, MD, PhD, FACS, New Sight Pharma
-
Sunil Patel MD, PhD, Allgenesis Biotherapeutics
Panel Judges:
-
Vartan Ghazarossian, PhD, CEO, Stepwise Medical
-
Ranya G. Habash, MD, CEO, Lifelong Vision
-
Richard L. Lindstrom, MD, Founder, Minnesota Eye Consultants
-
William J. Link, PhD, Managing Partner, Flying-L Partners
Presenting Company Showcase:
Retina, Therapeutics, and Technology + Devices
2:00 – 3:55 p.m.
A diverse line up of 40+ companies, more than half appearing at Eyecelerator for the first time, will present novel treatments and technologies at all stages of production in a unique, interactive format. Audience members are invited to ask questions.
Breakout rooms will operate simultaneously for each segment. Follow these links for showcase schedules:
THERAPEUTICS SHOWCASE: IMPLANTS AND PHARMACEUTICALS
TECHNOLOGY AND DEVICES SHOWCASE
Networking Break
3:55 – 4:15 p.m.
Find refreshments and connect with your colleagues.
Generation Next: Leveling Up a New Wave of Leaders
4:15 – 4:45 p.m.
Moderator Preeya K. Gupta, MD, engages a panel of inspired leaders who are bringing the future of ophthalmology into focus. Each offers a distinct perspective on the industry and the requirements for bringing innovation into the marketplace.
Moderator: Preeya K. Gupta, MD
Panelists:
-
Andrew Chang, Global Head of Sales, Ophthalmic Devices, Carl Zeiss Meditec
-
Ranna Jaraha, Executive Director New Media, BMC
-
Bindu Manne, Head, Market Development and Commercialization, Ocuphire
-
Maaza Martin, MS, Senior Director, Marketing, Tarsus Pharmaceuticals
Company Awards and Closing Bell
4:45 – 5:00 p.m.
Moderators: Allen C. Ho, MD and Julie Schallhorn, MD
Best of Show awards presented